Trial site
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 30running trials
- 24closed trials
The trials here
What the 54 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer8 trials
- Prostate cancer7 trials
- Lung cancer6 trials
- Myelodysplastic syndromes6 trials
- Acute myeloid leukaemia5 trials
- Ovarian cancer5 trials
- Acute lymphoblastic leukaemia4 trials
- Childhood cancers4 trials
- Sarcoma4 trials
- Triple-negative breast cancer4 trials
- Cervical cancer3 trials
- Chronic myeloid leukaemia3 trials
- and 20 more
- Phase
- Phase 219 trials
- Phase 110 trials
- Phase 37 trials
- Phase 1/25 trials
- Early phase 12 trials
- Phase 2/32 trials
- Status
- Active, not recruiting17 trials
- Completed16 trials
- Recruiting13 trials
- Terminated8 trials
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins26 trials
- AIDS Malignancy Consortium3 trials
- Hoffmann-La Roche3 trials
- Pfizer3 trials
- Incyte Corporation2 trials
- and 17 more
Running trials
Recruiting
Recruiting
Recruiting
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
Recruiting
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Recruiting
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Recruiting
Recruiting
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
Recruiting
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Active, not recruiting
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
Active, not recruiting
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Active, not recruiting
Recruiting
Active, not recruiting
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
Active, not recruiting
Active, not recruiting
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Active, not recruiting
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myelodysplastic syndromes3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Childhood cancers2 recruiting
- Chronic myeloid leukaemia2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Aplastic anaemia1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- HIV1 recruiting
- Hodgkin lymphoma1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Completed
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Terminated
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
Completed
Completed
Completed
Completed
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
Terminated
Terminated
Terminated
Terminated
Completed
Recruiting
Terminated
Completed
Terminated
Completed
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Completed
Resiliency in Older Adults Undergoing Bone Marrow Transplant
Completed
Completed
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
Completed
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026